Commerzbank Aktiengesellschaft FI Sells 21,100 Shares of Xylem Inc. $XYL

Commerzbank Aktiengesellschaft FI decreased its holdings in shares of Xylem Inc. (NYSE:XYL) by 19.4% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 87,868 shares of the industrial products company’s stock after selling 21,100 shares during the quarter. Commerzbank Aktiengesellschaft FI’s holdings in Xylem were worth $10,500,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in the stock. Commonwealth Retirement Investments LLC bought a new stake in shares of Xylem during the 4th quarter valued at approximately $27,000. Wexford Capital LP acquired a new position in Xylem during the 3rd quarter worth approximately $27,000. Global Assets Advisory LLC bought a new position in Xylem in the 1st quarter valued at approximately $40,000. FWL Investment Management LLC acquired a new stake in Xylem in the second quarter valued at approximately $43,000. Finally, Entrust Financial LLC bought a new stake in shares of Xylem during the fourth quarter worth $45,000. 87.96% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

XYL has been the subject of a number of recent research reports. Barclays lowered their target price on Xylem from $156.00 to $154.00 and set an “overweight” rating for the company in a report on Wednesday, April 29th. Jefferies Financial Group upgraded shares of Xylem from a “hold” rating to a “buy” rating and upped their price target for the company from $130.00 to $140.00 in a research report on Thursday, June 25th. Oppenheimer dropped their price target on shares of Xylem from $160.00 to $158.00 and set an “outperform” rating for the company in a research note on Wednesday, April 29th. JPMorgan Chase & Co. cut their price target on shares of Xylem from $170.00 to $160.00 and set an “overweight” rating on the stock in a report on Thursday, April 16th. Finally, Citigroup reduced their price objective on shares of Xylem from $174.00 to $168.00 and set a “buy” rating on the stock in a research note on Wednesday, April 29th. Eight equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $153.15.

Xylem Stock Down 1.6%

Shares of Xylem stock opened at $120.82 on Tuesday. The firm has a market cap of $28.72 billion, a price-to-earnings ratio of 30.05, a PEG ratio of 1.75 and a beta of 1.03. Xylem Inc. has a one year low of $105.29 and a one year high of $154.27. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.46 and a quick ratio of 1.10. The stock’s 50-day moving average is $113.40 and its 200 day moving average is $123.26.

Xylem (NYSE:XYL) last released its quarterly earnings data on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share for the quarter, beating the consensus estimate of $1.09 by $0.03. The company had revenue of $2.12 billion during the quarter, compared to analyst estimates of $2.11 billion. Xylem had a net margin of 10.79% and a return on equity of 11.26%. Xylem’s revenue for the quarter was up 2.7% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.03 EPS. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. Equities research analysts anticipate that Xylem Inc. will post 5.51 EPS for the current year.

Xylem Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, June 25th. Investors of record on Thursday, May 28th were issued a $0.43 dividend. This represents a $1.72 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date was Thursday, May 28th. Xylem’s dividend payout ratio is currently 42.79%.

Insider Buying and Selling at Xylem

In other Xylem news, Director Jerome A. Peribere purchased 1,210 shares of the firm’s stock in a transaction that occurred on Monday, May 4th. The stock was bought at an average cost of $116.61 per share, with a total value of $141,098.10. Following the completion of the transaction, the director owned 27,209 shares of the company’s stock, valued at $3,172,841.49. The trade was a 4.65% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CAO Geri-Michelle Mcshane sold 4,269 shares of the company’s stock in a transaction on Thursday, May 7th. The shares were sold at an average price of $117.46, for a total value of $501,436.74. Following the completion of the transaction, the chief accounting officer owned 3,605 shares of the company’s stock, valued at $423,443.30. This trade represents a 54.22% decrease in their position. The SEC filing for this sale provides additional information. Corporate insiders own 0.32% of the company’s stock.

Xylem Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.